Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th, at 2:15 p.m. PT (5:15

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update


Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working

Sonova announces changes to its Board of Directors
Sonova announces changes to its Board of Directors
Sonova announces changes to its Board of Directors
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals

Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference
Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 43rd Annual JPMorgan Healthcare Conference on Tuesday, January 14, 2024, at approximately 10:30 a.m. PST at

Acadia Healthcare to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Acadia Healthcare to Participate in 43rd Annual J.P. Morgan Healthcare Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference, January 13-16, 2025, in San Francisco

Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the J.P. Morgan Healthcare

ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P

LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference


Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024.



On TIME Magazine’s 2024

RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Brain Stimulation has published two pivotal articles chronicling the unipolar cohort data

ICON Announces Appointment of Chief Operating Officer
ICON Announces Appointment of Chief Operating Officer


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO).



Barry is a

Ecological Threat Report 2025: Extreme Regen- und Trockenperioden werden zunehmend zum Katalysator für schwerwiegende Konflikte: https://www.irw-press.at/prcom/images/messages/2025/81577/instituteforeconomicsNR10292025_DE_PRcom.001.jpeg
Ecological Threat Report 2025: Extreme Regen- und Trockenperioden werden zunehmend zum Katalysator für schwerwiegende Konflikte

Rund 2 Milliarden Menschen – ein Viertel der Menschheit – leben derzeit in Regionen, die von einem moderaten bis starken Anstieg saisonaler Verschiebungen betroffen sind.

 

LONDON, UK /

GA-ASI präsentiert mit Flugtests des Collaborative Combat Aircraft YFQ-42A eine weitere Luftfahrtneuheit
GA-ASI präsentiert mit Flugtests des Collaborative Combat Aircraft YFQ-42A eine weitere Luftfahrtneuheit

San Diego, Kalifornien / ACCESS Newswire / 27. August 2025 / Mit dem Collaborative Combat Aircraft (CCA, kooperatives Kampfflugzeug) YFQ-42A, das von General Atomics Aeronautical Systems,

Global Sports Brand U.S. Polo Assn. Delivers Record $2.5 Billion in Retail Sales for 2024, Targets $3 Billion and 1,500 U.S. Polo Assn. Stores
Global Sports Brand U.S. Polo Assn. Delivers Record $2.5 Billion in Retail Sales for 2024, Targets $3 Billion and 1,500 U.S. Polo Assn. Stores

WEST PALM BEACH, FL / ACCESS Newswire / April 29, 2025 / USPA Global, the company that manages U.S. Polo Assn., the official brand of the United States Polo Association (USPA), announced that

Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations

ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator

 

BOSTON, MA / ACCESSWIRE / January 8, 2025 / Biotech startups often encounter administrative roadblocks

Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy

BASEL, CH / ACCESS Newswire / November 27, 2025 / Magnolia, a leading global Digital Experience Platform (DXP) provider, is excited to announce that renowned software entrepreneur and

ESE Entertainment Asset Bombee Selected As Exclusive Production Partner for FC Supra, Montreal Soccer Team
ESE Entertainment Asset Bombee Selected As Exclusive Production Partner for FC Supra, Montreal Soccer Team

Vancouver, British Columbia, October 14, 2025 – ESE Entertainment Inc. (TSXV: ESE) (OTCQX: ENTEF) (“ESE” or the “Company”) is pleased to announce that its subsidiary, Bombee Global

Die Angst vor der Schuldenblase
Die Angst vor der Schuldenblase

Egal, ob in den USA oder Japan. So langsam registrieren die Finanzmärkte, dass die weltweit grassierende Schuldenmacherei an ihre Grenzen stößt. In Japan erreichten die Anleihe-Renditen neue

Saturn Oil & Gas Inc. Announces 2025 Capital Budget and Guidance, Operational Update and Three-Year Outlook
Saturn Oil & Gas Inc. Announces 2025 Capital Budget and Guidance, Operational Update and Three-Year Outlook

Calgary, Alberta--(December 16, 2024) - Saturn Oil & Gas Inc. (TSX: SOIL) (OTCQX: OILSF) ("Saturn" or the "Company"), a light oil-weighted producer focused on unlocking value through the